Toxic Exposures Kathy L
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Chemical Threat Agents Call Poison Control 24/7 for Treatment Information 1.800.222.1222 Blood Nerve Blister Pulmonary Metals Toxins
CHEMICAL THREAT AGENTS CALL POISON CONTROL 24/7 FOR TREATMENT INFORMATION 1.800.222.1222 BLOOD NERVE BLISTER PULMONARY METALS TOXINS SYMPTOMS SYMPTOMS SYMPTOMS SYMPTOMS SYMPTOMS SYMPTOMS • Vertigo • Diarrhea, diaphoresis • Itching • Upper respiratory tract • Cough • Shock • Tachycardia • Urination • Erythema irritation • Metallic taste • Organ failure • Tachypnea • Miosis • Yellowish blisters • Rhinitis • CNS effects • Cyanosis • Bradycardia, bronchospasm • Flu-like symptoms • Coughing • Shortness of breath • Flu-like symptoms • Emesis • Delayed eye irritation • Choking • Flu-like symptoms • Nonspecific neurological • Lacrimation • Delayed pulmonary edema • Visual disturbances symptoms • Salivation, sweating INDICATIVE LAB TESTS INDICATIVE LAB TESTS INDICATIVE LAB TEST INDICATIVE LAB TESTS INDICATIVE LAB TESTS INDICATIVE LAB TESTS • Increased anion gap • Decreased cholinesterase • Thiodiglycol present in urine • Decreased pO2 • Proteinuria None Available • Metabolic acidosis • Increased anion gap • Decreased pCO2 • Renal assessment • Narrow pO2 difference • Metabolic acidosis • Arterial blood gas between arterial and venous • Chest radiography samples DEFINITIVE TEST DEFINITIVE TEST DEFINITIVE TEST DEFINITIVE TESTS DEFINITIVE TESTS • Blood cyanide levels • Urine nerve agent • Urine blister agent No definitive tests available • Blood metals panel • Urine ricinine metabolites metabolites • Urine metals panel • Urine abrine POTENTIAL AGENTS POTENTIAL AGENTS POTENTIAL AGENTS POTENTIAL AGENTS POTENTIAL AGENTS POTENTIAL AGENTS • Hydrogen Cyanide -
Nerve Agent - Lntellipedia Page 1 Of9 Doc ID : 6637155 (U) Nerve Agent
This document is made available through the declassification efforts and research of John Greenewald, Jr., creator of: The Black Vault The Black Vault is the largest online Freedom of Information Act (FOIA) document clearinghouse in the world. The research efforts here are responsible for the declassification of MILLIONS of pages released by the U.S. Government & Military. Discover the Truth at: http://www.theblackvault.com Nerve Agent - lntellipedia Page 1 of9 Doc ID : 6637155 (U) Nerve Agent UNCLASSIFIED From lntellipedia Nerve Agents (also known as nerve gases, though these chemicals are liquid at room temperature) are a class of phosphorus-containing organic chemicals (organophosphates) that disrupt the mechanism by which nerves transfer messages to organs. The disruption is caused by blocking acetylcholinesterase, an enzyme that normally relaxes the activity of acetylcholine, a neurotransmitter. ...--------- --- -·---- - --- -·-- --- --- Contents • 1 Overview • 2 Biological Effects • 2.1 Mechanism of Action • 2.2 Antidotes • 3 Classes • 3.1 G-Series • 3.2 V-Series • 3.3 Novichok Agents • 3.4 Insecticides • 4 History • 4.1 The Discovery ofNerve Agents • 4.2 The Nazi Mass Production ofTabun • 4.3 Nerve Agents in Nazi Germany • 4.4 The Secret Gets Out • 4.5 Since World War II • 4.6 Ocean Disposal of Chemical Weapons • 5 Popular Culture • 6 References and External Links --------------- ----·-- - Overview As chemical weapons, they are classified as weapons of mass destruction by the United Nations according to UN Resolution 687, and their production and stockpiling was outlawed by the Chemical Weapons Convention of 1993; the Chemical Weapons Convention officially took effect on April 291997. Poisoning by a nerve agent leads to contraction of pupils, profuse salivation, convulsions, involuntary urination and defecation, and eventual death by asphyxiation as control is lost over respiratory muscles. -
Warning: the Following Lecture Contains Graphic Images
What the новичок (Novichok)? Why Chemical Warfare Agents Are More Relevant Than Ever Matt Sztajnkrycer, MD PHD Professor of Emergency Medicine, Mayo Clinic Medical Toxicologist, Minnesota Poison Control System Medical Director, RFD Chemical Assessment Team @NoobieMatt #ITLS2018 Disclosures In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards, the American Nurses Credentialing Center’s Commission (ANCC) and the Commission on Accreditation for Pre-Hospital Continuing Education (CAPCE), states presenters must disclose the existence of significant financial interests in or relationships with manufacturers or commercial products that may have a direct interest in the subject matter of the presentation, and relationships with the commercial supporter of this CME activity. The presenter does not consider that it will influence their presentation. Dr. Sztajnkrycer does not have a significant financial relationship to report. Dr. Sztajnkrycer is on the Editorial Board of International Trauma Life Support. Specific CW Agents Classes of Chemical Agents: The Big 5 The “A” List Pulmonary Agents Phosgene Oxime, Chlorine Vesicants Mustard, Phosgene Blood Agents CN Nerve Agents G, V, Novel, T Incapacitating Agents Thinking Outside the Box - An Abbreviated List Ammonia Fluorine Chlorine Acrylonitrile Hydrogen Sulfide Phosphine Methyl Isocyanate Dibotane Hydrogen Selenide Allyl Alcohol Sulfur Dioxide TDI Acrolein Nitric Acid Arsine Hydrazine Compound 1080/1081 Nitrogen Dioxide Tetramine (TETS) Ethylene Oxide Chlorine Leaks Phosphine Chlorine Common Toxic Industrial Chemical (“TIC”). Why use it in war/terror? Chlorine Density of 3.21 g/L. Heavier than air (1.28 g/L) sinks. Concentrates in low-lying areas. Like basements and underground bunkers. Reacts with water: Hypochlorous acid (HClO) Hydrochloric acid (HCl). -
Section 2. Hazards Identification OSHA/HCS Status : This Material Is Considered Hazardous by the OSHA Hazard Communication Standard (29 CFR 1910.1200)
SAFETY DATA SHEET Nonflammable Gas Mixture: Arsine / Helium / Phosgene Section 1. Identification GHS product identifier : Nonflammable Gas Mixture: Arsine / Helium / Phosgene Other means of : Not available. identification Product use : Synthetic/Analytical chemistry. SDS # : 006605 Supplier's details : Airgas USA, LLC and its affiliates 259 North Radnor-Chester Road Suite 100 Radnor, PA 19087-5283 1-610-687-5253 24-hour telephone : 1-866-734-3438 Section 2. Hazards identification OSHA/HCS status : This material is considered hazardous by the OSHA Hazard Communication Standard (29 CFR 1910.1200). Classification of the : GASES UNDER PRESSURE - Compressed gas substance or mixture ACUTE TOXICITY (inhalation) - Category 4 GHS label elements Hazard pictograms : Signal word : Warning Hazard statements : Contains gas under pressure; may explode if heated. May displace oxygen and cause rapid suffocation. Harmful if inhaled. Precautionary statements General : Read and follow all Safety Data Sheets (SDS’S) before use. Read label before use. Keep out of reach of children. If medical advice is needed, have product container or label at hand. Close valve after each use and when empty. Use equipment rated for cylinder pressure. Do not open valve until connected to equipment prepared for use. Use a back flow preventative device in the piping. Use only equipment of compatible materials of construction. Prevention : Use only outdoors or in a well-ventilated area. Avoid breathing gas. Response : IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER or physician if you feel unwell. Storage : Protect from sunlight when ambient temperature exceeds 52°C/125°F. Store in a well- ventilated place. -
WHO Model List of Essential Medicines
WHO Model List of Essential Medicines 15th list, March 2007 Status of this document This is a reprint of the text on the WHO Medicines web site http://www.who.int/medicines/publications/essentialmedicines/en/index.html 15th edition Essential Medicines WHO Model List (revised March 2007) Explanatory Notes The core list presents a list of minimum medicine needs for a basic health care system, listing the most efficacious, safe and cost‐effective medicines for priority conditions. Priority conditions are selected on the basis of current and estimated future public health relevance, and potential for safe and cost‐effective treatment. The complementary list presents essential medicines for priority diseases, for which specialized diagnostic or monitoring facilities, and/or specialist medical care, and/or specialist training are needed. In case of doubt medicines may also be listed as complementary on the basis of consistent higher costs or less attractive cost‐effectiveness in a variety of settings. The square box symbol () is primarily intended to indicate similar clinical performance within a pharmacological class. The listed medicine should be the example of the class for which there is the best evidence for effectiveness and safety. In some cases, this may be the first medicine that is licensed for marketing; in other instances, subsequently licensed compounds may be safer or more effective. Where there is no difference in terms of efficacy and safety data, the listed medicine should be the one that is generally available at the lowest price, based on international drug price information sources. Therapeutic equivalence is only indicated on the basis of reviews of efficacy and safety and when consistent with WHO clinical guidelines. -
Adverse Health Effects of Heavy Metals in Children
TRAINING FOR HEALTH CARE PROVIDERS [Date …Place …Event …Sponsor …Organizer] ADVERSE HEALTH EFFECTS OF HEAVY METALS IN CHILDREN Children's Health and the Environment WHO Training Package for the Health Sector World Health Organization www.who.int/ceh October 2011 1 <<NOTE TO USER: Please add details of the date, time, place and sponsorship of the meeting for which you are using this presentation in the space indicated.>> <<NOTE TO USER: This is a large set of slides from which the presenter should select the most relevant ones to use in a specific presentation. These slides cover many facets of the problem. Present only those slides that apply most directly to the local situation in the region. Please replace the examples, data, pictures and case studies with ones that are relevant to your situation.>> <<NOTE TO USER: This slide set discusses routes of exposure, adverse health effects and case studies from environmental exposure to heavy metals, other than lead and mercury, please go to the modules on lead and mercury for more information on those. Please refer to other modules (e.g. water, neurodevelopment, biomonitoring, environmental and developmental origins of disease) for complementary information>> Children and heavy metals LEARNING OBJECTIVES To define the spectrum of heavy metals (others than lead and mercury) with adverse effects on human health To describe the epidemiology of adverse effects of heavy metals (Arsenic, Cadmium, Copper and Thallium) in children To describe sources and routes of exposure of children to those heavy metals To understand the mechanism and illustrate the clinical effects of heavy metals’ toxicity To discuss the strategy of prevention of heavy metals’ adverse effects 2 The scope of this module is to provide an overview of the public health impact, adverse health effects, epidemiology, mechanism of action and prevention of heavy metals (other than lead and mercury) toxicity in children. -
Toxic Industrial Chemicals
J R Army Med Corps 2002; 148: 371-381 J R Army Med Corps: first published as 10.1136/jramc-148-04-06 on 1 December 2002. Downloaded from Toxic Industrial Chemicals Introduction location to another. Depending on the The first chemical warfare agent of the available routes of movement, and quantity modern era, chlorine, was released with of chemical to be moved, transport can occur devastating effect on 22 April 1915 at Ypres, by truck or rail tank cars, over water by barge Belgium. Along a 4 mile front, German or boat, over land through above- or below- soldiers opened the valves of 1,600 large and ground pipelines and by air. 4,130 small cylinders containing 168 tons of Toxic chemicals may be produced by the chlorine.The gas formed a thick white cloud burning of materials (e.g., the burning of that crossed the first allied trenches in less Teflon produces perfluoroisobutylene) or by than a minute.The allied line broke, allowing their reaction if spilled into water (e.g. silanes the Germans to advance deep into allied produce hydrogen chloride and cyanides, territory. If the Germans had been fully hydrogen cyanide). prepared to exploit this breakthrough, the course and possibly the outcome of WWI Toxic Industrial Chemicals may have been very different. (TICs) Chlorine is a commodity industrial A Toxic Industrial Chemical (TIC) is defined chemical with hundreds of legitimate uses; it as: is not a "purpose designed" chemical warfare an industrial chemical which has a LCt50 agent. Phosgene, another commodity value of less than 100,000 mg.min/m3 in industrial chemical, accounted for 80% of any mammalian species and is produced in the chemical fatalities during WWI. -
Inorganic Arsenic Compounds Other Than Arsine Health and Safety Guide
OS INTERNATiONAL I'ROGRAMME ON CHEMICAL SAFETY Health and Safety Guide No. 70 INORGANIC ARSENIC COMPOUNDS OTHER THAN ARSINE HEALTH AND SAFETY GUIDE i - I 04 R. Q) UNEP UNITED NATIONS INTERNATIONAL ENVIRONMENT I'R( )GRAMME LABOUR ORGANISATION k\s' I V WORLD HEALTH ORGANIZATION WORLD HEALTH ORGANIZATION, GENEVA 1992 IPcs Other H EA LTH AND SAFETY GUIDES available: Aerytonitrile 41. Clii rdeon 2. Kekvau 42. Vatiadiuni 3 . I Bula not 43 Di meLhyI ftirmatnide 4 2-Buta101 44 1-Dryliniot 5. 2.4- Diehlorpheiioxv- 45 . Ac rylzi mule acetic Acid (2.4-D) 46. Barium 6. NIcihylene Chhride 47. Airaziiie 7 . ie,i-Buia nol 48. Benlm'.ie 8. Ep Ichioroli) Olin 49. Cap a 64 P. ls.ihutaiiol 50. Captaii I o. feiddin oeth N lene Si. Parai.tuat II. Tetradi ion 51 Diquat 12. Te nacelle 53. Alpha- and Betal-lexachloro- 13 Clils,i (lane cyclohexanes 14 1 kpia Idor 54. Liiidaiic IS. Propylene oxide 55. 1 .2-Diciilroetiiane Ethylene Oxide 5t. Hydrazine Eiulosiillaii 57. F-orivaldehydc IS. Die h lorvos 55. MLhyI Isobu I V I kcloiic IV. Pculaehloro1heiiol 59. fl-Flexaric 20. Diiiiethoaie 61), Endrin 2 1 . A iii in and Dick) 0in 6 I . I sh IIZiLI1 22. Cyperniellirin 62. Nicki. Nickel Caution I. and some 23. Quiiiloieiic Nickel Compounds 24. Alkthrins 03. Hexachlorocyclopeuladiene 25. Rsiiiethii ins 64. Aidicaib 26. Pyr rot ii,id inc Alkaloids 65. Fe nitrolhioit 27. Magnetic Fields hib. Triclilorlon 28. Phosphine 67. Acroleiii 29. Diiiiethyl Sull'ite 68. Polychlurinated hiphenyls (PCBs) and 30. Dc lianteth nil polyc h In ruiated letlilienyls (fs) 31. -
Piratox Sheet N5 Suffocating Agents and Phosphine
Edition of October 2011 Piratox sheet #5: "Suffocating agents and phosphine Indicative list of concerned agents: Toxic compounds with suffocating action - Phosgene (CAS number: 75-44-5) - Chlorine (CAS number: 7782-50-5) - Methyl isocyanate (CAS number: 624-83-9) - But also: o Ammonia (CAS number: 7664-41-7) o Diphosgene or surpalite (CAS number: 503-38-8) o Chloropicrin (CAS number: 76-06-2) o Fluorine (CAS number: 7782-41-4) o Perfluoroisobutylene (CAS number: 382-21-8) o Fumigants o Marketed industrial and domestic products - Phosphine or PH3 or Hydrogen Phosphide (CAS number: 7803-51-2). ! Key points not to forget The 1st emergency step is the extraction of victims from the hazard area: rescuers must possess suitable breathing and eye protection. At ambient temperature (20°C) most suffocating agents are gases that penetrate the body via the respiratory route. They are thus poorly or non-persistent, frequently limiting victim decontamination needs to simple undressing. Most suffocating agents are heavier than air. They affect the respiratory system: glottis, bronchi, alveoli and cause eye damage. In pre-hospital settings, avoid any physical exertion that could promote the onset of pulmonary oedema. In general, the shorter the symptom onset time, the more serious the intoxication and the more severe the symptoms. Treatment is symptomatic only. All symptomatic choking gas victims must encouraged to rest, in a sitting position, under oxygen. The duration of surveillance for symptomatic subjects is of at least 12 to 24 hours. For Phosphine (PH3): o victims must be undressed and showered; o toxicity is respiratory, cardiac, renal and neurological; o subjects having inhaled PH3 and presenting with significant initial manifestations shall be monitored in the hospital for 48 to 72 hours, due to the risk of delayed acute pulmonary oedema. -
Combustion and Pyrolysis Kinetics of Chloropicrin J.-C
Combustion and Pyrolysis Kinetics of Chloropicrin J.-C. Lizardo-Huerta, B. Sirjean, L. Verdier, R. Fournet, Pierre-Alexandre Glaude To cite this version: J.-C. Lizardo-Huerta, B. Sirjean, L. Verdier, R. Fournet, Pierre-Alexandre Glaude. Combustion and Pyrolysis Kinetics of Chloropicrin. Journal of Physical Chemistry A, American Chemical Society, 2018, 122 (26), pp.5735 - 5741. 10.1021/acs.jpca.8b04007. hal-01921757 HAL Id: hal-01921757 https://hal.univ-lorraine.fr/hal-01921757 Submitted on 14 Nov 2018 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Combustion and Pyrolysis Kinetics of Chloropicrin J.-C. Lizardo-Huerta1, B. Sirjean1, L. Verdier2, R. Fournet1, P.-A. Glaude1* 1 Laboratoire Réactions et Génie des Procédés, CNRS, Université de Lorraine 1 rue Grandville BP 20451 54001 Nancy Cedex, France 2 DGA Maîtrise NRBC, Site du Bouchet, 5 rue Lavoisier, BP n°3, 91710 Vert le Petit, France Corresponding author : Pierre-Alexandre Glaude Laboratoire Réactions et Génie des Procédés 1 rue Grandville BP 20451 54001 Nancy Cedex, France Email:[email protected] 1 Abstract Chloropicrin (CCl3NO2) is widely used in agriculture as a pesticide, weed-killer, fungicide or nematicide. -
ABC of Poisoning. Emergency Drugs: Agents Used in the Treatment Of
1984 1AFnT('AT VOT. TmFT 289 22 SEPTEMBER UIQnTCTIT utILtjTOTTRMAT vJV' _- - . _ 742 D.ll.lilm13 4=.-, TIM MEREDITH JANE CAISLEY ABC ofPoisoning GLYN VOLANS EMERGENCY DRUGS: AGENTS USED IN THE TREATMENT OF POISONING A readily available and practical guide to the drugs used in the treatment of / poisoning is important, since many of the agents concerned are used infrequently; some can be obtained only from selected poisons treatment centres, and others, although listed in textbooks, are not available in the United Kingdom; still others are now considered obsolete and, in some cases, actually dangerous. The article Is basen advice Lists ofrecommended drugs have been published by the Department of appendixah artiendixsHto basedcrcularcircuon HNhen(78) Health and Social Security, most recently as HN(62)13 and HN(78)23. DrHuSS s 23 Ougs of Special Value in the1This article is based on these earlier lists, although, necessarily, many more Treatment of Poisoning in drugs have been included and additional information is given on the Accident and Emergency indications for use, mode ofaction, presentation, and dosage. In future this Departments list will be revised as necessary, and copies will be available from the National Poisons Information Service. Agents used for local cleansing, reliefofpain, fluid replacement, oxygen, and the more general care of the injured patient are not included. The need for collaboration and discussion between doctors and pharmacists in the preparation ofthis list is readily apparent and we would welcome comments which may be taken into account in future revisions. (1) Recommended agents that are readily available The decision to stock individual items will depend on the expected ofthe hospital concerned. -
Process for the Synthesis of N-Methyl-N-Phenylaminoacrolein
Europäisches Patentamt *EP001477474A1* (19) European Patent Office Office européen des brevets (11) EP 1 477 474 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.7: C07C 221/00, C07C 223/02 17.11.2004 Bulletin 2004/47 (21) Application number: 03425306.2 (22) Date of filing: 13.05.2003 (84) Designated Contracting States: (72) Inventors: AT BE BG CH CY CZ DE DK EE ES FI FR GB GR • Banfi, Aldo HU IE IT LI LU MC NL PT RO SE SI SK TR 20131 Milano (IT) Designated Extension States: • Mancini, Alfredo AL LT LV MK 26020 Spinadesco (Cremona) (IT) (71) Applicant: Clariant Life Science Molecules (Italia) (74) Representative: Pistolesi, Roberto et al SpA Dragotti & Associati SRL 21040 Origgio (Varese) (IT) Galleria San Babila 4/c 20122 Milano (IT) (54) Process for the synthesis of N-methyl-N-phenylaminoacrolein (57) A process is disclosed for manufacturing N-me- thyl-N-phenylaminoacrolein of formula (I) wherein R is a C3-C4 alkyl, said process being charac- terized in that the reaction between N-methylformanilide and said alkyl vinyl ether of formula (III) is carried out in the presence of phosgene, diphosgene or triphosgene which comprises reacting N-methylformanilide and an in a solvent selected from dioxane, acetonitrile and/or alkyl vinyl ether of formula (III) chlorobenzene. EP 1 477 474 A1 Printed by Jouve, 75001 PARIS (FR) 1 EP 1 477 474 A1 2 Description [0003] More in details, compound (I) can be converted into Fenal, by reaction with compound (IV) [0001] This invention relates to the synthesis of N-me- thyl-N-phenylaminoacrolein of formula (I) 5 10 15 and its use for the preparation of 3-[3-(4-Fluorophenyl)- 1-(1-Methylethyl)-1H-Indol-2-yl]-2-Propenal (II), herein- after referred to as "Fenal", 20 in acetonitrile in the presence of POCl3, as disclosed in WO 84/82131 and US-4739073.